16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy

Recruiting N/A Interventional Study
Pneumothorax Pleural Effusion
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
124 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim of the study is to evaluate postoperative pain in patients receiving a small-bore (16F) chest drain compared to those receiving the standard large-bore (24F) chest drain after minimally invasive pulmonary lobectomy and/or segmentectomy.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Informed Consent signed by the patient (all sex and gender) * Patients' age from ≥ 18 to no age limit at time of study inclusion * American Society of Anaesthesiologists (ASA) physical status classification I to IV * Patients with resectable non-small cell lung cancer (NSCLC) …
Contacts

Helga Bachmann, MSc Clinical Research

+41 (0)61 328 71 70

helga.bachmann@usb.ch

CONTACT

Makhmudbek Mallaev, MD

+41 (0)61 556 51 89

makhmudbek.mallaev@usb.ch

CONTACT